SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A13 <br />
SCREENING FOR ACE INHIBITORS AND AT-II-ANTAGONISTS IN URINE BY LC-MSIMS<br />
Barbora MaraIikova 1 ,2, Wolfgang Weinmann 1 , Claudia A. Muellerl,' <br />
lInstitute <strong>of</strong> <strong>Forensic</strong> Medicine, University Hospital, Albertstr. 9, D 79104 Freiburg (Germany) <br />
Phone: ++49 7612036878, Fax: ++49 761 2036858, Email: muel1erc@ukl.uni-freiburg.de <br />
2University <strong>of</strong> Par dub ice, FCHT, Department <strong>of</strong> Analytical Chemistry, nam. Cs.legii 565, 53210 <br />
Pardubice, Czech Republic <br />
For the detection <strong>of</strong> Angiotensin-Converting Enzyme inhibitors (ACE inhibitors: enalapril, Iisinopril, <br />
perindopril, captopril, ramipril, cilazapril as prodrug and active drug) and Angiotensin-II-Receptor <br />
Antagonists (candesartan, eprosartan, irbesartan, \osartan, telmisartan, valsartan) an LC-MS/MS target <br />
screening method has been developed to be used in clinical and forensic toxicological analysis. These drugs <br />
are widely used for lowering blood pressure besides betablockers, diuretics and calcium channel blockers <br />
which have been the aim <strong>of</strong> our previous work [I] - and their intake after prescription or even the non<br />
compliance <strong>of</strong> patients, not taking the drugs, could have severe effects on traffic safety. Furthermore, <br />
overdosage <strong>of</strong>these drugs can cause severe lowering <strong>of</strong> the blood pressure. <br />
For method development by LC-MSIMS ESI and APCI mass spectra <strong>of</strong> the compounds have been <br />
compared. ESI was found to be more suitable in terms <strong>of</strong> sensitivity for the ACE inhibitors, whereas the <br />
AT -II-Receptor Antagonists were detectable by both ionization modes. <br />
Linearity for quantitation was found for captopril, cilazapril, enalapril, Iisinopril, perindopril, ramipril and <br />
ramiprilat in the range <strong>of</strong> 10 to 500 nglmL with ESI after extraction from urine. LOD was below 10 ng/ml <br />
in urine. In patients' urine samples the ACE inhibitors were detectable in their active form (carboxylic <br />
form) by electrospray ionization after intake <strong>of</strong> therapeutic doses. However, the active form was not <br />
available as reference substance for all compounds and had to be generated by hydrolysis <strong>of</strong> the esters. The <br />
internal standard still remains a problem for quantitative analysis, since deuterated compounds are not <br />
available. For patients' urine and serum samples Benazepril was used as internal standard for quantitation, <br />
since it was not prescribed for these patients. <br />
Method development for the sartanes included liquid-liquid extraction (LLE). LC-ESI-MRM was found to <br />
be suitable for target screening for these drugs after spiking to urine; irbesartan was detected in a forensic <br />
case. <br />
Results <strong>of</strong> the method development and applications to patients' urine and also some serum samples are <br />
presented. <br />
[1] Mueller CA, Baranda AB, Weinmann W. Screening for l,4-dihydropyridine calcium channel blockers<br />
in plasma and serum by solid-phase extraction and LC-MS-MS. J Mass Spectrom (in Press, <strong>2004</strong>).<br />
Keywords: ACE inhibitors, AT II antagonists, LC-MS/MS<br />
Page 127